🔗 Permalink

Inventor profile of:

Ravindra KUMAR

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-08-07

Top Assignees for applications by Ravindra KUMAR

The entities that hold a legal rights for patent applications filed by inventor KUMAR Ravindra:

Acceleron Pharma, Inc. 13 Cambridge, MA United States
ADIMAB, LLC 2 Lebanon, NH United States
Acceleron Pharma Inc. 2 Rahway, NJ United States
Accerelon Pharma Inc. 1 Cambridge, MA United States
DYAX CORP. 1 Burlington, MA United States

Recent patent applications by KUMAR Ravindra

Ravindra KUMAR from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-07

US20250249071A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#2 | 2025-08-07

US20250249070A1

Human necessities

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

#3 | 2025-07-31

US20250241988A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#4 | 2025-03-13

US20250082722A1

Human necessities

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

#5 | 2025-03-06

US20250074968A1

Chemistry; metallurgy

ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION

#6 | 2025-02-27

US20250066488A1

Chemistry; metallurgy

ACTRIIB BINDING AGENTS AND USES THEREOF

#7 | 2025-02-06

US20250042963A1

Chemistry; metallurgy

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

#8 | 2024-11-07

US20240366722A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS

#9 | 2024-09-12

US20240299493A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#10 | 2024-08-22

US20240277807A1

Human necessities

ACTRII PROTEINS AND USES THEREOF

#11 | 2024-08-22

US20240277806A1

Human necessities

ACTRII PROTEINS AND USES THEREOF

#12 | 2024-08-01

US20240252628A1

Human necessities

ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE

#13 | 2024-07-11

US20240226235A1

Human necessities

TREATMENTS FOR SYSTEMIC SCLEROSIS

#14 | 2024-06-06

US20240181007A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#15 | 2024-05-30

US20240174733A1

Chemistry; metallurgy

ACTRII PROTEINS AND USES THEREOF

#16 | 2023-09-14

US20230285506A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#17 | 2023-08-24

US20230265161A1

Chemistry; metallurgy

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

#18 | 2023-07-27

US20230233648A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#19 | 2023-07-20

US20230226146A1

Human necessities

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

#20 | 2023-06-15

US20230183319A1

Chemistry; metallurgy

VARIANT ACTRIIB PROTEINS AND USES THEREOF

#21 | 2023-06-08

US20230174620A1

Chemistry; metallurgy

ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION

#22 | 2023-05-04

US20230134083A1

Chemistry; metallurgy

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS

#23 | 2023-04-27

US20230129812A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#24 | 2022-10-20

US20220332778A1

Chemistry; metallurgy

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

#25 | 2022-10-06

US20220315642A1

Chemistry; metallurgy

SINGLE-ARM TYPE I AND TYPE II RECEPTOR FUSION PROTEINS AND USES THEREOF

#26 | 2022-09-29

US20220306724A1

Chemistry; metallurgy

Variant ActRIIB proteins and uses thereof

#27 | 2022-09-15

US20220289852A1

Chemistry; metallurgy

ALK7 antagonists and uses thereof

#28 | 2022-09-08

US20220281951A1

Chemistry; metallurgy

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

#29 | 2022-08-04

US20220242927A1

Chemistry; metallurgy

ALK4:actriib heteromultimers and uses thereof

#30 | 2022-07-28

US20220233697A1

Human necessities

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

#31 | 2022-06-02

US20220169996A1

Chemistry; metallurgy

TRUNCATED ACTRIIB-FC FUSION PROTEINS

#32 | 2022-04-21

US20220119491A1

Chemistry; metallurgy

ALK7:ActRIIB heteromultimers and uses thereof

#33 | 2022-03-31

US20220098559A1

Chemistry; metallurgy

ISOLATED GDF TRAP POLYPEPTIDE

#34 | 2022-03-31

US20220098309A1

Chemistry; metallurgy

ACTRIIB BINDING AGENTS AND USES THEREOF

#35 | 2021-10-21

US20210324040A1

Chemistry; metallurgy

Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides

#36 | 2021-09-30

US20210299220A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#37 | 2021-09-30

US20210299216A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#38 | 2017-10-26

US20170306028A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#39 | 2017-10-05

US20170281711A1

Human necessities

Activin type 2 receptor antibodies

InventorID:

1999497 ⎘